The International Tennis Integrity Agency (ITIA) today confirms that Moroccan tennis player Imran Sibille has accepted a one-month suspension under the Tennis Anti-Doping Programme (TADP), subject to completion of an ITIA-approved treatment programme.
Sibille, who reached a career-high world singles ranking of 1433 in January 2024, tested positive for cocaine following an in-competition doping control test at an ITF World Tennis Tour M25 event in Catalonia, Spain, on 9 March 2025.
Sibille admitted the Anti-Doping Rule Violation, and the ITIA accepted that the player’s use of the substance occurred out of competition and was unrelated to sports performance – referred to under the World Anti-Doping Code and TADP as a Substance of Abuse breach.
The default period of ineligibility for Substance of Abuse breaches is a three-month suspension, which can be further reduced to one month if the individual commits to a treatment plan approved by the ITIA. Sibille has elected to enter into a treatment programme.
As such, the one-month period of ineligibility commenced on the date Sibille entered into provisional suspension, on 8 May 2025, and will end on 7 June 2025. Should Sibille fail to complete the agreed treatment plan, the player will be subject to an additional two months of ineligibility.
While suspended, Sibille is prohibited from playing in, coaching at, or attending any tennis event authorised or sanctioned by the members of the ITIA (ATP, ITF, WTA, Tennis Australia, Fédération Française de Tennis, Wimbledon and USTA) or any national association.
The ITIA is an independent body established by its tennis members to promote, encourage, enhance, and safeguard the integrity of professional tennis worldwide.
To read the full decision, click here.
Ends
Published 04 June 2025 15:00
